Moreover, IFN fine-tunes immune activation by modulating the expression of ubiquitin-specific peptidase 18 (USP18), a key negative regulator of IFN signaling, which can prevent excessive immune activation and exhaustion, sustaining tumor cell sensitivity to immune surveillance [155]. Here, IFNA1 is linked to neoplasm.